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Abstract: By inhibiting Insulin-Like Growth Factor-1-Receptor (IGF-1R) signaling, Klotho (KL) acts
like an aging- and tumor-suppressor. We investigated whether KL impacts the aggressiveness of
liposarcomas, in which IGF-1R signaling is frequently upregulated. Indeed, we observed that a
higher KL expression in liposarcomas is associated with a better outcome for patients. Moreover,
KL is downregulated in dedifferentiated liposarcomas (DDLPS) compared to well-differentiated
tumors and adipose tissue. Because DDLPS are high-grade tumors associated with poor prognosis,
we examined the potential of KL as a tool for overcoming therapy resistance. First, we confirmed the
attenuation of IGF-1-induced calcium (Ca2+)-response and Extracellular signal-Regulated Kinase 1/2
(ERK1/2) phosphorylation in KL-overexpressing human DDLPS cells. KL overexpression also reduced
cell proliferation, clonogenicity, and increased apoptosis induced by gemcitabine, thapsigargin, and
ABT-737, all of which are counteracted by IGF-1R-dependent signaling and activate Ca2+-dependent
endoplasmic reticulum (ER) stress. Then, we monitored cell death and cytosolic Ca2+-responses
and demonstrated that KL increases the reticular Ca2+-leakage by maintaining TRPC6 at the ER and
opening the translocon. Only the latter is necessary for sensitizing DDLPS cells to reticular stressors.
This was associated with ERK1/2 inhibition and could be mimicked with IGF-1R or MEK inhibitors.
These observations provide a new therapeutic strategy in the management of DDLPS.
Keywords: klotho; cancer; liposarcoma; calcium; ER stress; translocon; IGF-1; ERK; gemcitabine;
TRPC6; channels
1. Introduction
The heterogeneous family of soft-tissue sarcomas (STS) encompasses rare malignant tumors
that arise from mesenchymal tissue. The histological and molecular analyses of these tumors
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allow for the identification of numerous histotypes, including liposarcomas (LPS) that display an
adipocytic differentiation and are divided into four histological subtypes: well-differentiated (WDLPS),
dedifferentiated (DDLPS), myxoid round cell (MRCLPS), and pleomorphic (PLPS) liposarcomas [1,2].
WDLPS are the most frequent LPS (40% of cases) and are associated with good prognosis. However,
in 10% of cases, they can dedifferentiate and give rise to DDLPS that are high-grade tumors. DDLPS
mainly occur de novo and account for 25% of all LPS. These tumors are associated with a poor
outcome [3] due to metastatic progression (17–30%), high local recurrence rates (41–57%) [4,5] and
high chemoresistance. By contrast, MRCLPS are radiosensitive and chemoresponsive. PLPS are highly
aggressive but, fortunately, very rare tumors (5% of LPS).
For now, complete surgical resection is the mainstay of therapy for LPS patients. Due to
the resistance of these tumors to standard chemotherapies [6], patients suffering from advanced,
unresectable, or metastatic LPS receive adriamycin- or gemcitabine-based regimens as palliative
treatments. Identifying new therapeutic strategies and response biomarkers is of the utmost importance
in order to manage high-grade LPS.
One of the altered pathways that is subject to targeted therapy is IGF-1R signaling. Indeed, IGF-1R
is upregulated in osteosarcoma (OS) tumors compared to normal tissue [7] and is associated with
a poor overall [8] and metastasis-free survival in cohorts of OS and STS patients [8,9]. Moreover,
its downstream effectors p-AKT and p-ERK were suggested as biomarkers for the local recurrence in
STS [10]. Both IGF-1 and IGF-2 mRNA [11] and IGF-1R [12] are upregulated in LPS tumors compared
to adipose tissue. Considering the importance of insulin/IGF-1 signaling in adipose tissue homeostasis,
as demonstrated by mice lacking IGF-1R/IR (Insulin Receptor) expression [13], and in oncogenesis [14],
IGF-1R inhibitors are attractive for LPS therapy. A drug synergistic screen suggested the combined
inhibition of IGF-1R and Cyclin-Dependent Kinase 4 (CDK4) as a promising strategy for DDLPS [15].
However, IGF-1R targeted therapies have proved to be disappointing in clinical trials [16], even in OS
and STS [17]. So, new strategies for inhibiting insulin/IGF-1 signaling are still needed as a monotherapy
or in combination with other drugs to overcome resistance.
KL (klotho) was first discovered in mice mutated for this gene: the animals displayed multiple
aging-like phenotypes and died prematurely [18]. The overexpression of kl in mice increases their
lifespan up to 19–30% [19]. KL encodes a transmembrane protein whose extracellular domain can
be shed by secretases and act as a soluble hormone [20]. The alternative splicing of the gene can
also produce a soluble form of the protein (KLs) that will be directly secreted into the extracellular
environment [21]. The transmembrane protein is an obligatory co-factor for FGF23 (Fibroblast Growth
Factor 23) and so, has a crucial role in the normal renal function and in phosphate and calcium (Ca2+)
homeostasis [22]. Moreover, KLs and membrane-bound KL exhibit anti-aging properties mainly by
inhibiting insulin/IGF-1 signaling and reducing oxidative stress [19]. Interestingly, kl knockout in mice
results in the absence of adipose tissue [18]. Indeed, Klotho regulates proliferation and adipogenic
differentiation of adipose-derived stem cells [23].
Numerous studies have shown that KL is frequently downregulated in cancer (gliomas, breast,
colorectal, lung cancers, etc.). KL exerts a tumor suppressive effect mainly through inhibition of
IGF-1 signaling [24,25]. Considering its role in adipose tissue homeostasis, we examined the clinical
relevance of KL in terms of the survival of LPS patients and the hypothetical alteration of its expression
in these tumors. Then, in a DDLPS cell line, we investigated the effect of KL overexpression on IGF-1
signaling and on tumoral phenotypes, especially chemoresistance. Finally, we identified the molecular
targets of KL and confirmed the involved mechanisms with two other DDLPS cell lines. Based on our
findings, we suggest a new potential therapeutic approach for the management of DDLPS, relying on
the disruption of intracellular Ca2+ homeostasis combined with endoplasmic reticulum (ER) stressors.
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2. Results
2.1. KL Expression Has a Prognostic Value for Liposarcoma Patients and Is Downregulated in DDLPS Tumors
First, we examined whether KL expression has a clinical relevance in terms of survival for
LPS patients. A Kaplan Meier analysis of 140 primary human LPS samples profiled on gene
expression microarrays (GSE30929) revealed a significant difference in survival times between the
two groups dividing patients according to KL expression level in tumors (Figure 1A). In the same
cohort, we compared histotypes and noticed that the KL expression is higher in WDLPS compared
to other tumors (Figure 1B). We next focused on DDLPS because of their relatively high prevalence
and chemoresistance.
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Figure 1. Klotho (KL) expression has a prognostic value for liposarc ma atients and is downregulated
in dedifferentiated liposarcom s (DDLPS) tu ors (A) Kaplan-Meier curves of the overall survival in
140 liposarcoma patients divided into high- an low-risk roups according t the expression lev l
of KL in tumors (high or low, cut-off = mean) determined by microarra s (dataset ID: GSE30929).
Higher KL expression is significantly associated with a better survival for liposarcomas (LPS) patients
(Log-rank test, p < 0.001). (B) A boxplot of KL mRNA expression in dedifferentiated (DDLPS, n = 40),
myxoid round cell (MRCLPS, n = 28), pleomorphic (PLPS, n = 20), and well-differentiated (WDLPS,
n = 52) liposarcomas profiled on a gene expression microarray (dataset ID: GSE30929). KL expression
is significantly (** p < 0.01 and *** p < 0.001) higher in WDLPS tumors compared to other histotypes.
(C) A boxplot of KL mRNA expression in adipose tissue (n = 49) and DDLPS tumors (n = 61) profiled
on gene expression microarray (GSE13506 and GSE21050, respectively) and normalized by GENT
database. KL expression is significantly (p < 0.001) reduced in DDLPS tumors compared to adipose
tissue. On the boxplots, the line in the middle of the box is the median; the whiskers are drawn down
to the 10th percentile and up to the 90th. Points below and above the whiskers are represented as
individual points.
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Since KL is expressed in normal adipose tissue [26], we investigated whether its expression is
significantly altered in DDLPS tumors. For that purpose, we used free publicly available data from
the GENT database, which provides processing and normalization of datasets produced by different
laboratories (Figure 1C). The data pointed out that KL is significantly downregulated in the 61 DDLPS
samples (GSE21050) analyzed by a gene expression microarray as compared to the 49 samples of
normal adipose tissue (GSE13506). As for now, unfortunately, there is no available dataset on KL
expression in tumors at the protein level. These results altogether show that KL mRNA expression is
downregulated in DDLPS, compared to normal tissue and well-differentiated tumors, and that a lower
expression is associated with a poorer prognosis for LPS patients. This turns Klotho into a potential
clinical biomarker in high-grade LPS and suggests that its loss could be a selective advantage for tumor
development. We hypothesized that this might be related to its action on IGF-1R signaling [27].
2.2. In the DDLPS Cell Line, Klotho Reduces IGF-1R-Dependent Signaling
To assess the cellular role of Klotho in high-grade LPS, we established a DDLPS cell line stably
expressing KL (IB115-KL) (Figure 2A). No KL expression was detected by western blotting in the
control cell line (IB115-empty vector). Then, we investigated whether Klotho inhibits IGF-1 signaling
in these cells.
Ligand binding induces IGF-1R auto-phosphorylation and activates two major pathways: the
Ras-Raf-mitogen activated protein kinase (MEK)-ERK (MAPKs) and the phosphatidylinositol 3-kinase
(PI3K)/AKT pathways. In addition, it also promotes an intracellular Ca2+-response whose effectors
remain to be clearly elucidated but include PI3K [28,29] and MEK activity (Supplemental Figure S1A).
First, AKT and ERK1/2 phosphorylation during IGF-1 stimulation were analyzed by western
blotting (Figure 2B). In contrast to previously published work on breast cancer [27], no difference
regarding IGF-1R auto-phosphorylation on Tyr1131 and no reproducible AKT inhibition were observed
between the control and KL-overexpressing cells. However, in resting conditions, Klotho significantly
reduced the ERK1/2 phosphorylation ratio about 30% compared to the control cell line (Figure 2B,C).
Moreover, upon IGF-1 stimulation, the ERK1/2 phosphorylation ratio remained significantly higher
in IB115-empty vector cells than in IB115-KL cells until 1 h of treatment. Maximal ERK1/2
phosphorylation was reached 15 min after IGF-1 addition, with a ratio of around 2.1 and 1.4 for
control and KL-overexpressing cell lines, respectively. Of note, ERK1/2 abundance did not significantly
vary across time and between cell lines (Figure 2D). Therefore, in the IB115 cell line, Klotho reduces
ERK1/2 phosphorylation level and prevents its hyperactivation during IGF-1 stimulation.
Then, we studied the cytosolic Ca2+-response to IGF-1 (Figure 2E). Whereas control cells
responded by large Ca2+ oscillations, only rare and small Ca2+ transients were obtained in
KL-overexpressing cells. Pretreating control cells with BMS-754807, a specific inhibitor of
IGF-1R/insulin receptor (Supplemental Figure S1B), mimicked the response profile of IB115-KL
cells (Figure 2E). Klotho has been described as an inhibitor of Transient Receptor Potential Canonical 6
(TRPC6) channel by blocking its exocytosis stimulated by serum growth factors as IGF-1 (through PI3K)
and reducing its plasma membrane expression [30–32]. Therefore, we investigated the implication
of TRPC6 in an IGF-1-induced Ca2+-response (Supplemental Figure S1C). No cytosolic oscillations
were observed in IB115 cells stimulated with IGF-1 in a Ca2+-free medium, thus showing that the
Ca2+-entry at the plasma membrane is necessary for an IGF-1-induced Ca2+-response. Furthermore,
pretreating control cell line with larixyl acetate, the specific inhibitor of TRPC6, prevented cytosolic
Ca2+ oscillations following IGF-1 stimulation.
This demonstrates that Klotho abrogates an IGF-1-induced Ca2+-response, which requires
TRPC6-dependent currents and is not completely inhibited by MEK inhibition (Supplemental
Figure S1A). So, in addition to ERK1/2, Klotho might eventually inhibit PI3K signaling independently
of AKT activation.
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Figure 2. In the DDLPS cell line, Klotho reduces IGF-1R-dependent signaling (A) Validation of
KL-overexpression in the IB115 cell line by western blotting after lentiviral transduction. The 135
kDa-band was not detected in the control cell line expressing the empty vector. Actin was used as a
loadi g control. (B) Western blot analysis of IGF-1Rβ, AKT, and ERK1/2 phosphorylation statuses
during stimulation with 20 nM IGF-1. F r the comparison of th ratios b tween the phosphorylated
form nd total protein during treatment, th results were all normalized to the control condition
(IB115-empty vector, t0) set to 1. Actin was use as the loading control. Imag s shown are representative
of at least three independ nt experiments. (C) Ev lution of th ratio between phosphorylated ERK1/2
and the total ERK1/2 (normalized to contr l condition set to 1) during IGF-1 (20 nM) stimul tion.
Histograms sum u six i dependent experiments and correspond to the mean ± Standard eviation
(SD) (* p < 0.05, ** p < 0.01 and *** p < 0.001). (D) Evoluti n of the total ERK1/2 abundance (n rmalized
to control condition set to 1) during IGF-1 (20 nM) stimulation. Data shown su marize six independent
experiments and correspond to medians with the interquartile range (IQR). (E) Variations of relative
cytosolic Ca2+ concentration ([Ca2+]cyt) were monitored by fluorescence video imaging in Fluo2-loaded
cells bathed in HBSS (2 mM Ca2+) medium, pretreated or not during 24 h with BMS-754807 (50 nM).
Human IGF-1 (20 nM) was added in the bath medium at 200 s. Each trace corresponds to the evolution
of [Ca2+]cyt in one cell. Data shown are representative of three independent experiments.
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2.3. KL Overexpression in a DDLPS Cell Line Decreases Its Tumorigenic Phenotypes
Since KL overexpression affects IGF-1R signaling in DDLPS cells, we investigated its effect
on several tumoral phenotypes modulated by IGF-1R including cell proliferation, clonogenicity,
and chemoresistance.
KL overexpression significantly decreased cell proliferation from the third day on, resulting in
about 30% reduction of cell count (on average 61,204 and 42,993 cells for the IB115-empty vector
and IB115-KL cell lines, respectively) after 6 days of cell culture (Figure 3A). Moreover, IB115-KL
cells had fewer clonogenic capacities than the control cell line (Figure 3B), thus confirming its tumor
suppressor role. On the other hand, the main cytotoxic molecules used for LPS patients were screened
(Figure 3C–E). After 72 h treatment, cell death was assessed using TMRM-staining (gemcitabine,
docetaxel) or MTT assay (doxorubicin). No relevant difference between the two cell lines was observed
with doxorubicin (Figure 3C) and docetaxel (Figure 3D). In contrast, KL overexpression significantly
sensitized to gemcitabine-induced cell death (Figure 3E). KL overexpression does not decrease EC50
but rather enhances the magnitude of the plateau observed on the dose-response curve: maximal cell
death rates reach about 39% and 63% in the IB115-empty vector and IB115-KL cells, respectively.
Gemcitabine targets dividing cells and differently alters cell cycle depending on the concentration,
as described by Cappella and collaborators [33] and noticed in IB115 cells (Supplemental Figure S2).
Indeed, after its activation by phosphorylation, gemcitabine has a biphasic effect: first a cytostatic and
then a cytotoxic effect. This explains the delayed apoptosis, but alterations of cell cycle vary from one
concentration to another. Considering that Klotho does not interfere with the cell cycle disruption
induced by gemcitabine (Supplemental Figure S2), we hypothesized that, after 72 h of treatment,
its pro-apoptotic action mainly occurs at moderate (100 nM) and high concentrations (100 µM) of
gemcitabine at the end of the cytostatic phase and during the recovery phase. The fact that Klotho
promotes caspase-dependent apoptotic signaling was confirmed with a dual AnnexinV/PI staining
(Supplemental Figure S3).
These results are consistent with previous work showing that IGF-1 signaling protects cells from
gemcitabine-induced cell death in pancreatic cancer [34]. It is worth noting that IGF-1 signaling is
also well-known for protecting cells from ER stress-induced apoptosis by increasing the adaptive
capacity of ER [35]. ER stress was already implicated in resistance to gemcitabine [36,37]. Therefore,
we tested the hypothesis that, by inhibiting IGF-1 signaling, Klotho could sensitize DDLPS cells
to ER stress-inducing agents. Therefore, DDLPS cell lines were incubated with thapsigargin (TG),
an inhibitor of Sarco-Endoplasmic Reticulum Ca+-ATPase (SERCA) pumps (Figure 3F) and thus,
an ER stress inducer. TMRM-staining demonstrates that Klotho dramatically sensitizes DDLPS
cells to TG-induced cell death (EC50 = 28.2 vs. 6.32 nM for IB115-empty vector and IB115-KL cells,
respectively). Similar results were obtained with ABT-737, a BH3-mimetic that inhibits anti-apoptotic
proteins and consequently increases the Ca2+ transfer from ER to mitochondria, thus reducing reticular
Ca2+ content [38] (Figure 3G). Indeed, the EC50 of ABT-737 was shifted from 995 nM in IB115-empty
vector cells to 407 nM in IB115-KL cells.
These results indicate the specific role of Klotho in gemcitabine and ER-stress-induced apoptosis
in DDLPS cells. In order to confirm IGF-1R implication in resistance to apoptosis, the control cell
line was incubated with sub-lethal concentrations of BMS-754807 (Figure 3H,I). IGF-1R inhibition
significantly increased the cell death caused by TG (Figure 3H) or gemcitabine (Figure 3I) in a
dose-dependent manner.
These data confirm that IGF-1R signaling, which is partially inhibited by Klotho, promotes DDLPS
cell survival during TG and gemcitabine treatments.
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Figure 3. KL overexpression in a DDLPS cell line decreases its tumorigenic phenotypes. (A) Cell
proliferation was assessed by flow cytometry as described in Material and Methods. KL significantly
decreased the cell number at days 3, 5, and 6 (with * p < 0.05, ** p < 0.01 and *** p < 0.001,
respectively). Results summarize the three independent experiments and correspond to the medians
with IQR. (B) Clonogenicity was measured by crystal violet staining in accordance with the protocol
explained in the Material and Methods. Data shown are representative of the results obtained in three
independent experiments. (C) The viability of IB115 cell lines after 72 h of incubation with several
concentrations of doxorubicin was assessed by MTT assay. The results are represented as a percentage
of the control condition (with the median and IQR) and summarize three independent experiments.
(D–G) Mitochondrial potential loss assay was evaluated by flow cytometry with TMRM-loaded cells
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after 72 h of incubation with (D) docetaxel, (E) gemcitabine, (F) thapsigargin (TG), and (G) ABT-737,
according to the protocol described in the Material and Methods. Compared to corresponding
conditions with IB115-empty vector cells, KL-overexpression significantly (p < 0.001) enhanced cell
death induced by gemcitabine, thapsigargin, and ABT-737. Dose-response curves were interpolated
as standard slopes. The data shown summarize the results obtained in at least three independent
experiments and correspond to median and IQR. Cell death of IB115 cell lines was measured
by TMRM-staining and flow cytometry. IB115 cell lines were pretreated for 1 h with indicated
concentrations of BMS-7548074 and then treated for 72 h with (H) 10 nM thapsigargin (TG) or (I) 100 nM
gemcitabine. Compared to non-pretreated IB115-empty vector cells, BMS-7548074 significantly
increased the TG and gemcitabine-induced cell death in a dose-dependent manner. Histograms
sum up (H) four and (I) three independent experiments. Data shown correspond to medians with IQR.
2.4. KL-Overexpression Sensitizes DDLPS to ER Stress by Disrupting Intracellular Calcium Homeostasis
Klotho might sensitize cells to TG by affecting the SERCA expression. According to gene
expression microarray analysis, SERCA1 and SERCA3 genes are not (or only a few) transcribed
while the SERCA2 gene is highly expressed in IB115 cells (Supplemental Figure S4). Furthermore,
in adipose tissue, no SERCA1 protein is detected and SERCA3 is only slightly expressed according to
the Human Protein Atlas database. In contrast, SERCA2 is upregulated in LPS compared to normal
tissues and high SERCA2 expression is associated with high malignant LPS such as DDLPS [39,40].
Through western blotting, we found that Klotho does not affect the expression of SERCA2 (Figure 4A).
Long-term exposition to TG induces ER stress and activation of the Unfolded Protein Response
(UPR), which encompasses several pathways that activate both cell death and survival mechanisms.
The balance between these pathways determines cell fate and is modulated by IGF-1 signaling.
In pancreatic cancer, actors of the UPR are activated by gemcitabine and some of them, especially
XBP-1 (X-box binding protein 1), are implicated in chemoresistance [36,37]. We hypothesized that
Klotho might sensitize DDLPS cells to apoptosis by affecting ER stress pathways.
The analysis of the activation of several arms of the UPR (Figure 4A) confirmed that gemcitabine
treatment activates ER stress signaling in the IB115 cell line, although it has only a modest effect on
the expression of the chaperone protein GRP78/BiP (Binding immunoglobulin Protein), which is a
well-known marker of ER stress and so, is massively expressed during TG treatment.
Interestingly, Klotho enhances BiP expression (Figure 4A), even in resting conditions with about
a 4-fold increase, suggesting either a basal reticular stress in these cells or an effect related to the
Ca2+-binding activity of BiP in the lumen of the ER.
During the TG treatment, KL overexpression reduces XBP-1 splicing but enhances the
eIF2α activation as illustrated by the stronger induction of the pro-apoptotic CHOP (Figure 4A),
an observation that is consistent with increased apoptosis and reduced IGF-1 signaling [41].
With gemcitabine, this effect of Klotho on eIF2α-dependent signaling is also observed, while the
detection of spliced XBP-1 here rather reflects a more intense ER stress. An increased cell death in
KL-overexpressing cells is illustrated by higher PARP cleavage (Figure 4A).
Enhanced ER stress in IB115-KL cells might originate from a depletion of reticular Ca2+. To address
whether Klotho increases the ER stress by modulating the ER Ca2+-content, we measured the relative
cytosolic Ca2+ concentration ([Ca2+]cyt) in cells bathed in a Ca2+-free medium and applied TG
(Figure 4B), which passively depletes ER stores, or ionomycin (Figure 4C), a Ca2+ ionophore that
reveals the size of the Ca2+ stores. Strikingly, the Ca2+-release following TG treatment was greatly
increased in KL-overexpressing cells, as the subsequent capacitive Ca2+-entry (Figure 4B), whereas
the Ca2+-response to ionomycin was similar in both cell lines. These data suggested that the KL
overexpression enhances reticular Ca2+-leak but has no effect on the size of the Ca2+ stores. Direct
assessment of reticular calcium concentration ([Ca2+]ER) with a genetic Ca2+-sensor specifically targeted
to ER confirmed that Klotho neither alters resting [Ca2+]ER nor enhances the reticular Ca2+ pools
releasable by ionomycin, but significantly enhances the amplitude of the [Ca2+]ER decrease induced by
TG (Supplemental Figure S5).
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This implies that, in resting conditions, an increased Ca2+-leakage is compensated by active ER
re-filling, probably through the increased activity of SERCA pumps. On the other hand, Ca2+ released
into cytosol might probably be buffered by mitochondria. The estimation of mitochondrial Ca2+-content
by addition of CCCP (mitochondrial oxidative phosphorylation uncoupler) confirmed a greater
accumulation of Ca2+ in mitochondria of IB115-KL cells (Supplemental Figure S6A). Moreover,
the application of TG into the extracellular medium induced a significantly higher increase of relative
mitochondrial [Ca2+] in KL-overexpressing cells compared to the control cell line (Supplemental
Figure S6B). Therefore, during the long-term TG treatment, increased cell death observed in IB115-KL
cells may originate from increased ER stress (through reticular Ca2+-stores depletion) and a probable
mitochondrial Ca2+ overload.
Afterward, we investigated the effect of gemcitabine on reticular Ca2+-content of control cell line
after 24 and 48 h of treatment (Figure 4D,E). Intracellular Ca2+-mobilization following TG addition and
subsequent capacitive Ca2+-entry are increased in a time-dependent manner (Figure 4D): the amplitude
of Ca2+-responses have doubled after 48 h of treatment with gemcitabine. However, no significant
difference is observed with ionomycin (Figure 4E). So, gemcitabine-induced ER stress is associated
with a reticular Ca2+-leak that increases over time.
In this context, increased capacitive Ca2+-entry seems to be a consequence of enhanced
intracellular Ca2+-mobilization rather than a direct target of Klotho. Moreover, the inhibition
of Calcium Release-Activated Channels (CRAC) by BTP2 did not protect IB115-KL cells from
gemcitabine-induced cell death (Supplemental Figure S7). Actually, BTP2 even tended to
sensitize control cell line to gemcitabine, although the differences were not statistically significant.
So, the enhanced capacitive Ca2+-entry might be mainly involved in intracellular stores refilling and
does not play a major role in gemcitabine-induced cell death.
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and IB115-cells, respectively), but (C) did not affect the Ca2+ ER content, compared to IB115-empty vector
cell line (n = 79 and n = 123 for the IB115-empty vector and IB115-cells, respectively). (D,E) IB115-empty
vector cells were pretreated with gemcitabine (100 nM) during 24 and 48 h. Gemcitabine increased
(D) TG-induced Ca2+ response (control n = 96; 24 h, n = 82; 48 h, n = 34) but (E) did not alter the size of
the reticular Ca2+ pools (control n = 102; gemcitabine n = 81).
To conclude, TG application revealed that Klotho promotes a constitutive reticular Ca2+-leakage.
This probably contributes to the greater sensitivity to ER stressors such as TG, ABT-737, or gemcitabine,
resulting in a higher CHOP induction, possible mitochondr al Ca2+- verlo d, and e l de th.
2.5. Intracellular Localization of TRPC6 Contributes to Reticular Ca2+-Leakage in KL-Overexpressing
DDLPS Cells
In order to identify the molecular mechanisms by which Klotho increases reticular Ca2+-leakage,
we first hypothesized that this could involve the Transient Receptor Potential Canonical 6 (TRPC6)
channel. Indeed, in neural cancer cells, TRPC6 can be translocated to the reticulum and this localization
results in an increase in passive Ca2+-efflux without any modification of the reticular Ca2+ content [42].
So, as previously reported in other models, Klotho could modulate the TRPC6 intracellular localization
in DDLPS cells, thereby explaining its inhibitory action on the IGF-1-induced Ca2+-response.
To test this hypothesis, DDLPS cells were stimulated with 50 µM of OAG, a structural analog
of DAG (DiAcylGlycerol) that activates Ca2+ entry through TRPC-3,-6 channels [43]. After the OAG
addition, a large cytosolic [Ca2+] increase was observed in IB115-empty vector cells bathed in the
Ca2+-containing medium, but not in Ca2+-free medium, meaning that the previous cytosolic Ca2+
increase was due to a Ca2+ influx through TRPC channels at the plasma membrane (Figure 5A).
In IB115-KL cells bathed in a Ca2+-containing extracellular medium, OAG induced a smaller (about
50% decrease) transie t Ca2+ peak, which was only partially affected by the absence of Ca2+ in the
extracellular medium (Figure 5B). This sugg sts that in thes cells, OAG mainly mobilized calcium
ions stored in an intracellular c mpartment. The pretreatment of IB115-KL cel s with TG abolished
OAG-induced intracellular Ca2+ release (Figure 5C), suggesting that the OAG-sensitive channels are
mainly located at the ER membrane and mobilize Ca2+ from TG-sensitive reticular stores.
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To confirm the TRPC6 implication, the cells were bathed in a Ca2+-free medium and stimulated
with Hyp9, a specific activator of TRPC6. Similar to OAG stimulation, a cytosolic Ca2+-response was
recorded in IB115-KL but not the B115-empty vector cells (Figure 5D). The pretreatment of IB115-KL
cells with TRPC6 inhibitors (U73343 or larixyl acetate) significantly reduced the amplitude of the
Ca2+-response to OAG (Figure 5E) and to TG (Figure 5F), thus confirming the role of TRPC6 in both
OAG-induced response and the passive reticular Ca2+-leak. Pretreatment with a specific inhibitor
of TRPC3 (Pyr3) combined to larixyl acetate suppressed OAG-response (Supplemental Figure S8).
Therefore, it can be hypothesized that the residual Ca2+-response to OAG in larixyl acetate-treated
cells is mediated by TRPC3 channels. However, to our knowledge, there is no evidence of the role of
TRPC3 at the ER or for a link between IGF-1, KL, and TRPC3 in the literature. So, the mechanisms
involving TRPC3 would require further investigation. Comparing Ca2+-response of Pyr3- and larixyl
acetate-treated cells suggests that TRPC3 is less implicated than TRPC6 in Ca2+-response to OAG
(Supplemental Figure S8).
The analysis of TRPC6 abundance by western blotting revealed that TRPC6 expression is increased
after 48 h incubation with 10 nM TG or 100 nM gemcitabine and, more importantly, in IB115-KL cells
(Figure 5G). This suggests that TRPC6 might play a role in TG- and gemcitabine-induced cell death.
Though larixyl acetate (the specific TRPC6 inhibitor) reduced the TG-induced Ca2+-response,
no protection against TG-induced apoptosis was observed in IB115-KL cells (Figure 5H). Actually,
TRPC6 inhibition aggravated TG-induced apoptosis in both cell lines (Figure 5H), while it did not
meaningfully modify cell death after gemcitabine treatment (Figure 5I). However, larixyl acetate does
not allow for the distinction between respective roles of reticular- and plasma membrane-located
TRPC6 channels. Previous studies reported that TRPC6 takes part in the Ca2+-entry induced by
TG [44–46]. The sensitization to apoptosis observed in IB115-empty vector cells (Figure 5H) suggests
that the influx of Ca2+ through the TRPC6 channels at the plasma membrane is involved in cell survival.
Despite the fact that intracellular TRPC6 channels take part in TG-induced Ca2+-release and
so, probably promote ER stress, these last results altogether suggest that TRPC6 sequestration at
the ER is probably not the only and major mechanism by which Klotho sensitizes to TG- and
gemcitabine-induced cell death.
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Figure 5. The intracellular localization of TRPC6 contributes to reticular Ca2+-leakage in KL-
overexpressing DDLPS cells, but is not necessary to increase cell death. (A–F) Variations of relative 
cytosolic Ca2+ concentration were monitored by fluorescence videomicroscopy in Fluo2-loaded cells. 
Each experiment was repeated three times and the average of more than 20 single-cell traces was 
analyzed. The effect of OAG (50 µM) addition was evaluated in (A) IB115-empty vector or (B) IB115-
KL cells bathed in HBSS medium ± 2 mM Ca2+, and in (C) IB115-KL cells pretreated with TG (10 nM) 
at 200 s in a Ca2+-free HBSS medium. (D) IB115 empty-vector and IB115-KL cells were bathed in a 
Ca2+-free HBSS medium and stimulated at 200 s by the specific activator of TRPC6 Hyp9 (1 M). (E) 
OAG (50 µM) was added at 200 s to Ca2+-free HBSS medium on IB115-KL cells control or pretreated 
with inhibitors of TRPC6 (U73343 and larixyl acetate both at 1 M, 1 h). (F) Ca2+-leakage was estimated 
by the application of 10 nM TG at 200 s on IB115-empty vector or IB115-KL cells, which were 
pretreated or not with larixyl acetate (1 M, 1 h), in a Ca2+-free HBSS medium. (G) The abundance of 
TRPC6 was analyzed in IB115-empty vector and IB115-KL cells by western blotting after 48 h of 
incubation with no drugs, 10 nM TG, or 100 nM gemcitabine. Actin was used as a loading control. To 
compare TRPC6 abundance between conditions, results were all normalized to control conditions 
(IB115-empty vector, no treatment). Results shown are representative of three independent 
experiments. (H,I) Cell death was measured with a TMRM-staining analyzed by flow cytometry after 
72 h incubation of IB115 cell lines, which were pretreated during 1 h with indicated concentrations of 
larixyl acetate and then treated with (H) 20 nM and 10 nM TG for the IB115-empty vector and IB115-
KL cells, respectively (in order to have nearly similar cell death rates), or (I) 100 nM gemcitabine. 
Histograms sum up (H) four and (I) two independent experiments. Data shown correspond to 
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2.6. In DDLPS Cells, Klotho Promotes Reticular Ca2+ Leakage and Apoptosis by Opening the Translocon 
According to the literature, the major effector of the reticular Ca2+-leak is the translocon (TLC) 
[47], a protein complex that allows for the translocation of nascent polypeptides into the ER lumen 
for elongation and maturation. When the polypeptidic chain is released, Ca2+ leaks through the pore 
of the TLC, which is, at that time, in an open state for Ca2+. Puromycin and anisomycin are antibiotics 
that inhibit protein synthesis but, respectively, open and close the TLC [47]. 
Interestingly, puromycin had no effect in IB115-empty vector cells (Figure 6A), whereas it 
elicited a huge transient increase in [Ca2+]cyt followed by Ca2+-oscillations in IB115-KL cells (Figure 
6B). These were drastically reduced by anisomycin pretreatment (Figure 6C). TLC closure by 
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analyzed in IB115-empty vector and IB115-KL cells by western blotting after 48 h of incubation with no
drugs, 10 nM TG, or 100 nM gemcitabine. Actin was used as a loading control. To compare TRPC6
abundance between conditions, results were all normalized to control conditions (IB115-empty vector,
no treatment). Results shown are representative of three independent experiments. (H,I) Cell death
was measured with a TMRM-staining analyzed by flow cytometry after 72 h incubation of IB115 cell
lines, which were pretreated during 1 h with indicated concentrations of larixyl acetate and then treated
with (H) 20 nM and 10 nM TG for the IB115-empty vector and IB115-KL cells, respectively (in order
to have nearly similar cell death rates), or (I) 100 nM gemcitabine. Histograms sum up (H) four and
(I) two independent experiments. Data shown correspond to medians (IQR).
2.6. In DDLPS Cells, Klotho Promotes Reticular Ca2+ Leakage and Apoptosis by Opening the Translocon
According to the literature, the major effector of the reticular Ca2+-leak is the translocon (TLC) [47],
a protein complex that allows for the translocation of nascent polypeptides into the ER lumen for
elongation and maturation. When the polypeptidic chain is released, Ca2+ leaks through the pore of
the TLC, which is, at that time, in an open state for Ca2+. Puromycin and anisomycin are antibiotics
that inhibit protein synthesis but, respectively, open and close the TLC [47].
Interestingly, puromycin had no effect in IB115-empty vector cells (Figure 6A), whereas it elicited
a huge transient increase in [Ca2+]cyt followed by Ca2+-oscillations in IB115-KL cells (Figure 6B).
These were drastically reduced by anisomycin pretreatment (Figure 6C). TLC closure by anisomycin
significantly reduced the TG-induced Ca2+-release (Figure 6D), thereby confirming that TLC is
implicated in the basal reticular Ca2+-leakage.
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Figure 6. In DDLPS cells, Klotho promotes reticular Ca2+-leakage and apoptosis by opening the 
translocon. (A–E) Variations of relative cytosolic Ca2+ concentration were monitored by fluorescence 
videomicroscopy in Fluo2-loaded cells. Data shown are representative of three independent 
experiments. (A–C) In a Ca2+-free HBSS medium, puromycin (25 µg/mL) was applied at 200 s on (A) 
IB115-empty vector cells, (B) IB115-KL cells, and on (C) IB115-KL cells pretreated 30 min with 200 nM 
anisomycin, a translocon-closing molecule. Each trace corresponds to the evolution of [Ca2+]cyt in one 
cell. (D) In a Ca2+-free HBSS medium, IB115-KL cells, pretreated (n = 114) or not (n = 76) with 200 nM 
anisomycin during 30 min, were stimulated at 200 s with TG (10 nM) to evaluate reticular Ca2+-
leakage. Results are represented as means ± SD. (E) In a Ca2+-free HBSS medium, IB115-empty vector 
cells, pretreated (n = 78) or not (n = 81) with 100 nM gemcitabine during 24 h, were stimulated at 200 
s with puromycin (25 µg/mL) to assess Ca2+-leakage through the translocon. Results are represented 
as means ± SD. (F,G) Cell death was measured by TMRM-staining and flow cytometry in IB115 cell 
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(Supplemental Figure S11). The Wortmannin pretreatment had only a slight effect on TG-induced 
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effect on apoptosis induced by gemcitabine (Figure 7C) in both cell lines. By contrast, PD98059 
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200 M anisomycin, a tra sloco -closing molecule. Each t ace corresponds to the ev lution of [Ca2+]cyt
in one cell. (D) In a Ca2+-free HBSS edium, IB115-KL cells, pretreated (n = 114) or not (n = 76) with
200 nM anisomyci during 30 min, were stimulated at 200 s with TG (10 nM) to evaluate reticular
Ca2+-leakage. Results are represented as means ± SD. (E) In a Ca2+-free HBSS medium, IB115-empty
vector cells, pretreated (n = 78) or not (n = 81) with 100 nM gemcitabine during 24 h, were stimulated
at 200 s with puromycin (25 µg/mL) to assess Ca2+-leakage through the translocon. Results are
represented as means ± SD. (F,G) Cell death was measured by TMRM-staining and flow cytometry in
IB115 cell lines pretreated for 1 h with 200 nM anisomycin and then incubated for 72 h with (F) 10 nM
TG or (G) 100 nM gemcitabine. Histograms sum up (F) three and (G) four independent experiments.
Data shown correspond to medians and IQR.
In addition, puromycin triggered a cytosolic Ca2+-response in IB115-empty vector cells pretreated
with gemcitabine (Figure 6E). Thi demonstrates that the gemcitabine-induced Ca2+-leak ge is
mediated at lea t in par by opening the TLC.
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Anisomycin significantly reduced the death rates of IB115-KL cells after 72 h incubation with TG
(Figure 6F) or gemcitabine (Figure 6G). The protective effect towards gemcitabine in both cell lines
was not due to protein synthesis inhibition because puromycin did the opposite and was counteracted
by anisomycin on the wild-type IB115 cell line (Supplemental Figure S9A). Moreover, the long-term
treatment with anisomycin did not affect KL-overexpression (Supplemental Figure S9B). Furthermore,
anisomycin reduced BiP expression in resting conditions and during gemcitabine treatment, but not
the other reticular chaperone protein calreticulin (Supplemental Figure S9B). To conclude, anisomycin
reduces ER stress by limiting the TLC-mediated Ca2+-leakage, which is induced by gemcitabine and
enhanced by Klotho.
Altogether, these results demonstrate that in KL-overexpressing cells, a higher proportion of TLCs
is in an open-state. This contributes to the basal reticular Ca2+-leakage revealed by TG treatment and
aggravates the gemcitabine-induced TLC opening. This results in reticular Ca2+-depletion in IB115-KL
cells after 48 h of treatment (Supplemental Figure S9C), in contrast to control cells (Figure 4D,E), and in
increased apoptosis.
All major results concerning the effect of Klotho on TLC opening and reticular stress were
confirmed in two other DDLPS cell lines (IB111 and IB143) (Supplemental Figure S10). Indeed,
KL overexpression increases BiP expression (Supplemental Figure S10A), Ca2+-response to puromycin
(Supplemental Figure S10B) and to TG (Supplemental Figure S10C), and also cell death rates following
long-term treatment with TG (Supplemental Figure S10D) or gemcitabine (Supplemental Figure S10E).
To conclude, despite different genetic backgrounds and an intrinsic greater resistance to ER stress
in IB111 and IB143 compared to IB115, Klotho increases TLC-opening and reticular Ca2+-leakage in
both cell lines and significantly sensitizes them to cell death induced by TG or gemcitabine. Lower
expression of KL in transduced IB111 and IB143 cells compared to IB115-KL cell line is one possible
explanation for the more discrete effects on the phenotypes (Supplemental Figure S10A).
Then, we investigated which IGF-1 signaling pathway is implicated in the resistance to ER
stressors and is inhibited by Klotho and addressed its impact on reticular Ca2+-leakage.
2.7. Klotho Regulates Drug Sensitivity and Reticular Ca2+-Leakage by Inhibiting ERK1/2 Signaling
Two pathways of the IGF-1R signaling, ras/raf/MEK/ERK and PI3K/AKT, are known to
play a role in the resistance to gemcitabine [48,49] and ER stress [50–52]. Since Klotho inhibits
the IGF-1-induced Ca2+-response (mainly dependent on PI3K, see Supplemental Figure S1A) and
ERK1/2 activation, we have studied the phosphorylation status of AKT and ERK1/2 after the TG and
gemcitabine treatments (Figure 7A). AKT was de-phosphorylated after incubation with TG and only
slightly phosphorylated after gemcitabine treatment. In contrast, ERK1/2 is phosphorylated in control
cells after each treatment, but this activation is inhibited in KL-overexpressing cells. Thus, suggesting
that ERK1/2 is implicated in resistance to TG and gemcitabine but not AKT.
This was confirmed with the use of PI3K (Wortmannin) and MEK (PD98059) inhibitors
(Supplemental Figure S11). The Wortmannin pretreatment had only a slight effect on TG-induced cell
death of IB115-empty vector cells (Figure 7B), but not of IB115-KL cells, and had no significant effect
on apoptosis induced by gemcitabine (Figure 7C) in both cell lines. By contrast, PD98059 significantly
potentiated the apoptotic response to TG and gemcitabine (Figure 7B,C) in both cell lines. These results
altogether demonstrate that ERK1/2 but not AKT exerts a relevant pro-survival activity against ER
stressors and is inhibited by Klotho in this DDLPS cell line.
Finally, we addressed the consequence of IGF-1R and MEK inhibition on reticular Ca2+-leakage. First,
the pretreatment of control cells with BMS-754807 (Figure 7D) or PD98059 (Figure 7E) restored the reticular
Ca2+-leakage induced by puromycin and observed in IB115-KL cells. Then, both inhibitors mimicked
the effect of Klotho on TG-induced Ca2+-response (Figure 7F) without affecting the ER Ca2+-content
(Supplemental Figure S12). Therefore, IGF-1R and, more precisely, the ERK inhibition is at least one
mechanism by which Klotho promotes reticular Ca2+-leakage through the TLC and so, sensitizes these
DDLPS cells to ER stressors releasing Ca2+ from reticular stores (such as TG, gemcitabine, and ABT-737).
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(A) Analysis by Western blotting of the abundance of phosphorylated AKT and ERK1/2 compared
to total protein expression, in IB115-empty vector and IB115-KL cells after 48 h of incubation with
no drugs, 10 nM thapsigargin (TG) or 100 nM gemcitabine. Actin was used as a loading control.
To compare the ratios between phosphorylated form and total protein during treatments, results
were all normalized to the control condition (IB115-empty vector, no treatment) set to 1. Results are
representative of three independent experiments. (B,C) Cell death was measured by TMRM-staining
and flow cytometry. IB115 cell lines were pretreated for 2 h with Wortmannin or PD98059 as indicated
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and then incubated for 72 h with (B) 20 nM or 10 nM TG for IB115-empty vector and IB115-KL cells,
respectively (in order to have an almost similar cell death), or (C) 100 nM gemcitabine. Histograms
sum up (B) four (with median and IQR) and (C) three (represented as means ± SD) independent
experiments. (D–F) Variations of relative cytosolic Ca2+ concentration were monitored by fluorescence
videomicroscopy, in Fluo2-loaded cells bathed in a Ca2+-free HBSS medium. (D,E) Puromycin
(25 µg/mL) was added at 200 s to IB115-empty vector cells pretreated with (D) BMS-754807 (50 nM,
24 h) or (E) PD98059 (1 µM, 2 h). Each trace corresponds to the evolution of [Ca2+]cyt in one cell.
Data shown are representative of three independent experiments. (F) TG (10 nM) was added at
200 s to IB115-KL cells (n = 83) and IB115-empty vector cells, which were not pretreated (n = 77) or
pretreated with BMS-754807 (50 nM, 24 h, n = 78) or PD98059 (1 µM, 2 h, n = 75). Results correspond to
means ± SD.
3. Discussion
In this work, we evaluated the relevance of Klotho as a biomarker and as a tool for overcoming
drug resistance in high-grade LPS.
We reported that a higher KL expression is associated with better survival of LPS patients.
Moreover, its expression is detected at higher levels in WDLPS, which has a good prognosis.
KL expression is critical for adipose tissue homeostasis but is altered in DDLPS, probably by epigenetic
regulations as in several other cancers [53,54]. If in the future the normal tissue of each patient were
to be systematically sampled during tumor excision, it would be interesting to confirm these clinical
results at the protein level by comparing KL abundance in DDLPS tumors with matched-adipose
tissue. Meanwhile, considering our observations at the transcriptomic level, KL downregulation may
represent a selective advantage for tumor cells and so, may be associated with tumor evolution as
for DDLPS.
In compliance with this observation, we did not detect, by western blotting, endogenous KL
expression in any of the six DDLPS cell lines, isolated from the patients’ tumors, available in the lab.
Moreover, for most of these cell lines, KL overexpression was rapidly eliminated by the transduced
cells despite effective lentiviral transduction and cell selection.
To assess the cellular role of Klotho in DDLPS, we successfully established a DDLPS cell line
stably overexpressing KL. Its inhibitory action on IGF-1-dependent Ca2+-signaling was shown through
TRPC6 sequestration at the ER and on ERK1/2 activation. Analysis of tumor phenotypes indicated
that Klotho reduces cell proliferation, clonogenicity, and has a major effect on drug sensitivity and
Ca2+ homeostasis.
Because Ca2+ signaling is involved in several hallmarks of cancer, Ca2+ remodeling in cancer cells
is a research field of growing interest [55]. Here, we have demonstrated for the first time, in three
DDLPS cell lines, that Klotho increases reticular Ca2+-leakage by opening the TLC. This effect on the
TLC is supported by the compensatory upregulation of BiP in KL-overexpressing cells because BiP
interacts with the TLC complex and by this way limits Ca2+-leakage through the pore [56]. However,
to the best of our knowledge, the link between the permeability of the TLC to Ca2+ and IGF-1R or
ERK1/2 activity is unknown. This new and unexpected mechanism will require further investigation.
The constitutive Ca2+-leakage confers to the DDLPS cells overexpressing KL a greater susceptibility
to apoptosis mediated by ER-stressors such as thapsigargin (TG), ABT-737, and gemcitabine,
whose effect on TLC openings had never been described until now. This sensitization by Klotho
is also related to a greater induction of CHOP, which promotes the transcription of pro-apoptotic
genes and aggravates the reticular Ca2+-leakage [57]. In addition, an increased Ca2+-transfer from the
ER to mitochondria might stimulate ATP production in resting conditions and promote ER refilling
by SERCA pumps, but probably also results in mitochondrial Ca2+-overload and mitochondrial
membrane potential loss during the exposure to these ER stressors.
These results are in conflict with previous work showing that Klotho protects from ER stress [58].
However, KL-overexpressing DDLPS cells share interesting similarities with dwarf fibroblasts during
TG treatment, like increased apoptosis, reduced XBP-1 splicing, and preserved activation of eIF2α [41].
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These fibroblasts were isolated from Snell dwarf mice, a longevity model that bears a homozygous
mutation in the gene encoding Pit-1, resulting in several deficiencies in growth hormones including
IGF-1. Indeed, insulin/IGF-1 signaling inhibition is a mechanism shared by many animal longevity
models including KL-overexpressing mice [19,59]. Moreover, IGF-1 signaling was reported as a
cytoprotective pathway against canonical ER stress [35,60], but also against gemcitabine [34] and
ABT-737 [61]. All these observations are consistent with our results showing a potentiated apoptotic
response to ER stressors mediated by the inhibition of IGF-1-dependent signaling in KL-overexpressing
DDLPS cells. Therefore, the role of Klotho on ER stress might depend on a cellular context.
Discrepancies between results might also arise from the fact that Banerjee et al. overexpressed
mouse KL [58], which is not identical to human KL and could differ in terms of interactions with
human proteins.
The inhibition of IGF1-R and MEK mimicked the effect of Klotho on Ca2+ homeostasis and
sensitized to TG- and gemcitabine-induced cell death. Actually, there are numerous crosstalks between
MAPK signaling and ER stress [62]. The MEK-ERK pathway was shown to promote cell survival
during ER stress. ER stress signaling can also directly activate ERK1/2. Indeed, IRE-1 activation can
stimulate ERK1/2 through an unknown mechanism. Reduced XBP-1 splicing in KL-overexpressing
cells, which suggests a reduced IRE-1 activation, can be involved in attenuated ERK1/2 activation and
so, in increased cell death. In addition, BiP can be translocated to the plasma membrane and activate
the signaling cascade Ras-Raf-MEK-ERK. So, given that ERK1/2 is less activated in KL-overexpressing
cells despite enhanced ER stress, Klotho may probably act through additional pathways in parallel
to IGF-1R in order to avoid the hyperactivation of MAPK signaling. Considering that Ca2+ and the
reactive oxygen species can modulate ERK1/2 activity and that Klotho regulates both, this provides
new possibilities for investigation. Moreover, Klotho is a regulator of pathways that are commonly
altered in cancer and activate MAPK, such as Wnt and FGF [25]. Its use in the therapeutic management
of DDLPS is thus probably not restricted to IGF-1R inhibition.
Regarding reticular TRPC6, its activity as a passive leaky channel had already been reported but,
until now, the only regulator identified for that mechanism was the Stromal Interacting Molecule 1
(STIM1) [42]. Here, we observed that the IGF-1-induced Ca2+ response requires TRPC6 and that MEK
inhibition promotes the sequestration of active TRPC6 channels at the ER. So, the effects of Klotho on
IGF-1-induced Ca2+ signaling and reticular Ca2+-leak through TRPC6 could be related to the regulation
of STIM-1 by ERK1/2 [63]. Nevertheless, additional experiments are needed to test this hypothesis
and physiological consequences remain to be studied.
For the first time, we bring evidence of a role for Klotho in LPS. If our results were confirmed
in vivo, combining Klotho’s mechanism of action and ER stressors might be an alternative for DDLPS
patient care. Indeed, LPS frequently overexpress SERCA2 and calreticulin [39,64] and, consequently,
are sensitive to ER stressors [39]. By enhancing Ca2+-leakage-mediated ER stress, Klotho could
increase the calreticulin exposure at the surface of tumor cells and so, facilitate immunogenic cell death.
Considering the emerging improvements in immunotherapy, this question will certainly be addressed
in the future.
4. Materials and Methods
4.1. Chemicals
Doxorubicin (Adriamycin; Pfizer, New York, NY, USA) and gemcitabine (Gemzar; Eli Lilly and
Company, Neuilly-sur-Seine, France) were obtained from the pharmacy of the Bergonié Institute
(Bordeaux, France). Docetaxel (Taxotere; Sanofi-Aventis, Gentilly, France) was obtained from
Sigma-Aldrich (St. Quentin Fallavier, France). ABT-737 was purchased from Selleckchem (Munich,
Germany).
About the other chemicals—thapsigargin, puromycin, anisomycin, ionomycin, Hyp9, OAG,
U73343, and Wortmannin—were from Sigma-Aldrich. BMS-754807 and PD98059 were purchased from
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Selleckchem. Larixyl acetate was obtained from Santa Cruz Biotechnology (Dallas, TX, USA). Pyr3 was
from Calbiochem (Merck Millipore, Darmstadt, Germany). Human IGF1 was from Miltenyi Biotec
(Paris, France). QVD-OPh was purchased from R&D Systems (Minneapolis, MN, USA).
4.2. Cell Lines
The dedifferentiated liposarcoma cell lines IB111, IB115, and IB143 were a generous gift
from F. Chibon (INSERM U1218, Bergonié Cancer Institute, Bordeaux) and were established and
authenticated as previously described [65]. DDLPS and HEK-293T cell lines were respectively
cultured in RPMI-1640/GlutaMAX-I and DMEM/GlutaMAX-I media (Life Technologies Inc., brand of
ThermoFisher Scientific, Waltham, MA, USA) supplemented with 10% Foetal Bovine Serum (FBS).
Cells were grown at 37 ◦C in a humidified atmosphere containing 5% CO2. Cultures were periodically
tested for mycoplasma contamination.
IB111, IB115, and IB143 cells were infected with a lentiviral vector encoding human
transmembrane KL (EX-Z9677-Lv105, GeneCopoeia, Rockville, MD, USA). Control cell lines were
established with lentiviral transduction of an empty vector (pReceiver-Lv105, GeneCopoeia, Rockville,
MD, USA). VSV-G-pseudotyped lentiviral particles were produced by co-transfection of HEK293T
cells with previous vectors and the compatible packaging plasmids psPAX2 and pVSVg. Cell lines
were incubated overnight with lentiviral supernatants and 8 µg/mL of polybrene (Sigma-Aldrich,
St. Quentin Fallavier, France). Stably transduced cells were selected with puromycin (1 µg/mL, Sigma).
Then, puromycin was removed from the culture medium. KL overexpression was regularly verified
over passages by Western blotting.
4.3. Western Blot
For IGF-1 stimulation, the cells were harvested overnight before IGF-1 addition into an FBS-free
culture medium. For protein extraction, cells were rinsed with ice-cold PBS and lysed for 30 min
at 4 ◦C in RIPA lysis and extraction buffer (Sigma) supplemented with a protease/phosphatase
inhibitor cocktail (Sigma-Aldrich, St. Quentin Fallavier, France), 5 mM sodium orthovanadate
(New England Biolabs, Ipswich, MA, USA), 1 mM EGTA, and 10 mM sodium fluoride (Sigma-Aldrich,
St. Quentin Fallavier, France). Lysates were pelleted 10 min at 17,000× g, 4 ◦C and supernatants were
collected for protein quantitation (DC protein assay kit, Biorad, Hercules, CA, USA). After denaturation,
25 µg total proteins of each sample were separated by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis and transferred to polyvinylidene difluoride membranes (iBlot2, ThermoFisher
Scientific, Waltham, MA, USA) for immunoblotting with the appropriate primary antibody at 4 ◦C
overnight. Anti-KL antibodies were purchased from Sigma-Aldrich (St. Quentin Fallavier, France)
(#SAB2104815 and #SAB2105026) and ThermoFisher Scientific (Waltham, MA, USA) (PA5-21078).
Antibodies for detection of P-IGF1Rβ (Tyr1131) (#3021), p-AKT (Ser473) (#4060), AKT (#4685),
p-ERK1/2 (Thr202/Tyr204) (#9101), ERK1/2 (#9101), BiP (#3177), p-eIF2α (Ser51) (#3597), XBP-1s
(#12782), c-PARP (Asp214) (#5625), SERCA2 (#4388) and calreticulin (#12238) were obtained from Cell
Signaling Technology (Danvers, MA, USA). Antibodies for IGF-1Rβ (#sc-713), eIF2α (#sc-11386), and
CHOP (#sc-793) were from Santa Cruz Biotechnology (Dallas, TX, USA). Anti-TRPC6 (#ACC-120)
was provided by Alomone Labs (Jerusalem, Israel). Anti-actin (#A2066) was from Sigma-Aldrich
(St. Quentin Fallavier, France). After washing, blots were incubated for 1 h with a horseradish
peroxidase-linked anti-rabbit antibody (Sigma-Aldrich, St. Quentin Fallavier, France) and processed
for a chemiluminescent substrate (ThermoFisher Scientific, Waltham, MA, USA) according to the
manufacturer’s instructions. The signal was detected using Fusion Fx7 (ThermoFisher Scientific,
Waltham, MA, USA) imaging system. Actin was used as a loading control and the quantification of
protein abundance was performed by blot densitometry using the ImageJ 1.48v software (Rasband,
W.S., ImageJ, U. S. National Institutes of Health, Bethesda, MD, USA).
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4.4. Cell Proliferation
A total of 2500 cells were plated into 24-well plates in four replicates. Culture medium was
changed at days 0-3-5 (0.5 mL per well). After trypsinization, the cell number was evaluated by
flow cytometry (FACS Calibur, BD Biosciences, San Jose, CA, USA) based on their morphological
features (FSC/SSC). Data acquisition and analysis were performed with the BD PlateManager and BD
CellQuestPro software.
4.5. Clonogenic Assay
Totals of 100, 500, and 1000 cells were plated onto 6-well plates. Fresh culture medium was added
every 2 to 3 days. After 10 days, cells were washed with PBS, fixed with 70% ethanol, washed again
and then stained with a 1% Crystal Violet solution (Sigma-Aldrich, St. Quentin Fallavier, France).
After several rinses with water and drying, the plates were scanned.
4.6. MTT Assay
A total of 5000 cells were seeded into 96-well plates in six replicates. The day after, the culture
medium was replaced by a doxorubicin-containing medium (0.2 mL per well). After 72 h, 20 µL
of 5 mg/mL MTT substrate (Sigma-Aldrich, St. Quentin Fallavier, France) solution were added to
each well. Plates were incubated 2 h at 37 ◦C in a humidified atmosphere containing 5% CO2. Then,
the medium was discarded and formazan was dissolved in DMSO. Absorbance of each well was
measured with the microplate reader FlexStation 3 (Molecular Devices, San Jose, CA, USA) and
calculated (A570nm–A630nm). For each condition, the viability was calculated as a percent of control.
Dose-response curves were interpolated with Prism6 v6.01 (GraphPad Software Inc, La Jolla, CA, USA)
software as standard slopes.
4.7. Mitochondrial Potential Loss Assay (Tetramethylrhodamine, Methyl Ester, TMRM)
A total of 5000 cells were seeded into 96-well plates in at least three replicates. The day after, the
culture medium was replaced by drug-containing medium (0.2 mL per well). After 72 h of incubation,
200 nM TMRM dye (Fluka, brand of ThermoFisher Scientific, Waltham, MA, USA) and 20 µM verapamil
(Sigma-Aldrich, St. Quentin Fallavier, France) were added into medium. Plates were incubated at
37 ◦C, 5% CO2 for 30 min. Then, supernatants were collected, cells were trypsinized and resuspended
in their respective supernatants. TMRM-staining was analyzed by flow cytometry (FACS Calibur,
BD Biosciences, San Jose, CA, USA). Data acquisition and analysis were performed with the BD
PlateManager and BD CellQuestPro software. Cell population was determined on a FSC/SSC dot plot.
Then, the region corresponding to cells that lost their mitochondrial electric potential (TMRM-negative
cells) was selected on a SSC/FL2 dot plot diagram. The number of TMRM-negative cells is shown as a
percentage of the analyzed cell population. Dose-response curves were interpolated with Prism6 v6.01
(GraphPad Software Inc., La Jolla, CA, USA) software as standard slopes.
4.8. Cytosolic Calcium Imaging
For calcium imaging, 100,000 cells were seeded onto glass coverslips (25 mm dia.) and incubated in
a complete culture medium for 48 h. Single-cell cytosolic calcium imaging was performed, using Fluo2
LR-AM calcium dye as previously described [66]. Fluorescence intensity changes were normalized
to the initial fluorescence value F0 and expressed as F/F0 (relative [Ca2+]cyt). One field was acquired
from each coverslip and the data were pooled from six independent coverslips on three different days.
Data were processed using OriginPro 7.5 software (Origin Lab, Northampton, MA, USA). On graphs,
data were summarized as the mean ± standard deviation (SD).
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4.9. Statistical Analysis
The cohort of 140 primary liposarcomas is from Gobble et al. [67] (GSE30929). Data about patient
survival, histotypes and KL expression values (estimated with robust multi-array average (RMA)) were
obtained with the web tool GEO2R. Patients were divided into groups according to the KL expression
value (“high” or “low”, cut-off = mean). Survival rates were estimated using the Kaplan–Meier method
and compared using the log-rank test using XL-STAT v2018.1 (Addinsoft, Paris, France) software.
Each experiment was repeated at least three times. To examine the statistical significance of
the results, analyses were performed with the Prism6 v6.01 (GraphPad Software Inc, La Jolla, CA,
USA) software. The normal distribution of datasets was examined with a Shapiro–Wilk normality
test. If the data passed the normality test, the statistical significance between the two conditions was
assessed with an unpaired t-test and the results were represented as the mean ± standard deviation
(SD). Otherwise, a Mann–Whitney test was used and the median with interquartile range (IQR) was
plotted. For western blot experiments, paired tests were used. Significant differences are represented
as * if p-value p < 0.05, ** if p < 0.01 and *** if p < 0.001.
5. Conclusions
In this study, we evidence that Klotho is downregulated in DDLPS tumors and that its
re-expression in DDLPS cell lines enhances the apoptotic response to ER stressors. Its mechanism of
action mainly relies on the opening of the TLC, which mediates reticular Ca2+ leak and is induced by at
least the attenuation of the IGF-1/ERK signaling pathway. Further experiments should be performed
in order to identify the molecular players modulating TLC opening and regulated by ERK and Klotho.
This would provide new therapeutic targets for overcoming drug resistance of DDLPS.
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